secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quantum-Si Inc (QSI)
CIK:        0001816431
Form:       8-K
Filed at:   2026-10-08T20:12:07+00:00
Accession:  0001816431-26-000064
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Quantum-Si detects 19 amino acids in Proteus program; targets all 20 by year-end 2026, launch in Q2 2027
--------------------------------------------------------------------------------

- Quantum-Si demonstrated detection of 19 amino acids in its Proteus development program, up from the 18-amino-acid developmental kit presented at the 2026 World HUPO Congress.
- Company is now deploying the 19-amino-acid capability into a developmental sequencing kit for routine use on integrated Proteus instruments by its R&D team.
- CEO Jeff Hawkins said detection of all 20 amino acids is "well within reach by year-end 2026" and that the company is "growing increasingly confident" in hitting that milestone.
- Management expects the 19-amino-acid capability to further increase Proteus sequencing performance and reiterated its commercial launch target for the second quarter of 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816431/000181643126000064/0001816431-26-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816431/000181643126000064/qsi-20261008.htm
  HTML page:      https://secwatch.observer/filing/0001816431-26-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer